Neogenomics Inc (NASDAQ:NEO)

4.56
Delayed Data
As of 3:59pm ET
 +0.02 / +0.44%
Today’s Change
2.95
Today|||52-Week Range
6.10
+9.35%
Year-to-Date

Today’s Trading

Previous close4.54
Today’s open4.51
Day’s range4.50 - 4.60
Volume148,024
Average volume (3 months)234,651
Market cap$272.3M
Dividend yield--
Data as of 3:59pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+30.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratio226.8
Price/Sales2.56
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CPHRCipher Pharmaceutica...+0.35+3.04%
RDNTRadNet Inc+0.02+0.17%
NBSNeoStem Inc+0.02+0.53%
CTICCTi Biopharma Corp+0.04+1.50%
Data as of 3:59pm ET, 03/02/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account